Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	regulation of neurogenesis	HDAC6 SMURF1 FXN SYNGAP1 PARP6 RNF6 ASCL1 FBXO31 ULK1 ARHGEF2 TNFRSF1B SPEN	4.81e-06	515	96	12	GO:0050767
GeneOntologyBiologicalProcess	cell morphogenesis	NRN1L ROCK2 CACNA1A HDAC6 ANK3 SMURF1 TRIOBP FXN SYNGAP1 PARP6 KIRREL3 MYO3A RNF6 ABI2 FBXO31 HRH2 ULK1 ARHGEF2	8.66e-06	1194	96	18	GO:0000902
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	ROCK2 CACNA1A HDAC6 ANK3 SMURF1 TRIOBP FXN SYNGAP1 PARP6 MYO3A RNF6 ABI2 FBXO31 ULK1	9.18e-06	748	96	14	GO:0048667
GeneOntologyBiologicalProcess	neuron projection morphogenesis	NRN1L ROCK2 CACNA1A HDAC6 ANK3 SMURF1 FXN SYNGAP1 PARP6 KIRREL3 RNF6 ABI2 FBXO31 ULK1	2.00e-05	802	96	14	GO:0048812
GeneOntologyBiologicalProcess	neuron projection development	NRN1L ROCK2 CACNA1A HDAC6 ANK3 SMURF1 TRIOBP SPIRE1 FXN SYNGAP1 PARP6 KIRREL3 MYO3A PBRM1 RNF6 ABI2 FBXO31 ULK1	2.33e-05	1285	96	18	GO:0031175
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	NRN1L ROCK2 CACNA1A HDAC6 ANK3 SMURF1 FXN SYNGAP1 PARP6 KIRREL3 RNF6 ABI2 FBXO31 ULK1	2.52e-05	819	96	14	GO:0120039
GeneOntologyBiologicalProcess	dendrite development	ROCK2 CACNA1A HDAC6 SPIRE1 SYNGAP1 PARP6 PBRM1 ABI2 FBXO31	2.65e-05	335	96	9	GO:0016358
GeneOntologyBiologicalProcess	cell projection morphogenesis	NRN1L ROCK2 CACNA1A HDAC6 ANK3 SMURF1 FXN SYNGAP1 PARP6 KIRREL3 RNF6 ABI2 FBXO31 ULK1	2.77e-05	826	96	14	GO:0048858
GeneOntologyBiologicalProcess	regulation of axonogenesis	CACNA1A HDAC6 SMURF1 FXN SYNGAP1 RNF6 ULK1	3.22e-05	192	96	7	GO:0050770
GeneOntologyBiologicalProcess	regulation of nervous system development	HDAC6 SMURF1 FXN SYNGAP1 PARP6 RNF6 ASCL1 FBXO31 ULK1 ARHGEF2 TNFRSF1B SPEN	3.30e-05	625	96	12	GO:0051960
GeneOntologyBiologicalProcess	neuron development	NRN1L ROCK2 CACNA1A HDAC6 ANK3 SMURF1 TRIOBP SPIRE1 FXN SYNGAP1 PARP6 KIRREL3 MYO3A PBRM1 RNF6 ABI2 ASCL1 FBXO31 ULK1	3.79e-05	1463	96	19	GO:0048666
GeneOntologyBiologicalProcess	regulation of cell development	ROCK2 HDAC6 SMURF1 KAT2A FXN SYNGAP1 PARP6 PBRM1 RNF6 ASCL1 FBXO31 ULK1 ARHGEF2 TNFRSF1B SPEN LILRA4	4.28e-05	1095	96	16	GO:0060284
GeneOntologyBiologicalProcess	musculoskeletal movement, spinal reflex action	CACNA1A ASCL1	6.41e-05	3	96	2	GO:0050883
GeneOntologyBiologicalProcess	vestibular nucleus development	CACNA1A ASCL1	6.41e-05	3	96	2	GO:0021750
GeneOntologyBiologicalProcess	neuron migration	ADGRG1 KIRREL3 ABI2 ASCL1 FBXO31 ULK1 ARHGEF2	7.19e-05	218	96	7	GO:0001764
GeneOntologyBiologicalProcess	response to mitochondrial depolarisation	HDAC6 SMURF1 ULK1	1.62e-04	23	96	3	GO:0098780
GeneOntologyBiologicalProcess	negative regulation of axonogenesis	HDAC6 SYNGAP1 RNF6 ULK1	2.00e-04	62	96	4	GO:0050771
GeneOntologyBiologicalProcess	medulla oblongata development	CACNA1A ASCL1	2.12e-04	5	96	2	GO:0021550
GeneOntologyBiologicalProcess	positive regulation of neurogenesis	HDAC6 SMURF1 FXN PARP6 ASCL1 FBXO31 TNFRSF1B SPEN	2.48e-04	354	96	8	GO:0050769
GeneOntologyBiologicalProcess	regulation of extent of cell growth	HDAC6 SMURF1 FXN RNF6 ULK1	2.65e-04	122	96	5	GO:0061387
GeneOntologyBiologicalProcess	dendrite morphogenesis	ROCK2 CACNA1A HDAC6 PARP6 ABI2 FBXO31	3.28e-04	198	96	6	GO:0048813
GeneOntologyBiologicalProcess	mitophagy	HDAC6 SMURF1 ABI2 ULK1	4.16e-04	75	96	4	GO:0000423
GeneOntologyBiologicalProcess	neuron projection extension	NRN1L HDAC6 SMURF1 FXN RNF6 ULK1	4.16e-04	207	96	6	GO:1990138
GeneOntologyBiologicalProcess	axon extension	HDAC6 SMURF1 FXN RNF6 ULK1	4.23e-04	135	96	5	GO:0048675
GeneOntologyBiologicalProcess	type 2 mitophagy	HDAC6 SMURF1	4.43e-04	7	96	2	GO:0061734
GeneOntologyBiologicalProcess	regulation of anatomical structure morphogenesis	ROCK2 CACNA1A SP1 HDAC6 HIPK1 SMURF1 SPIRE1 FXN SYNGAP1 PARP6 RNF6 ABI2 FBXO31 ULK1	5.06e-04	1090	96	14	GO:0022603
GeneOntologyCellularComponent	somatodendritic compartment	NCOA2 CACNA1A KIF21B CACNA1S PDE4B HDAC6 ANK3 SMURF1 CHRM5 SYNGAP1 KIRREL3 ABI2 ASCL1 FBXO31 HRH2 ULK1 ARHGEF2 TNFRSF1B	1.06e-05	1228	96	18	GO:0036477
GeneOntologyCellularComponent	dendrite	NCOA2 CACNA1A KIF21B CACNA1S PDE4B HDAC6 ANK3 CHRM5 SYNGAP1 KIRREL3 ABI2 HRH2 ARHGEF2	1.48e-04	858	96	13	GO:0030425
GeneOntologyCellularComponent	dendritic tree	NCOA2 CACNA1A KIF21B CACNA1S PDE4B HDAC6 ANK3 CHRM5 SYNGAP1 KIRREL3 ABI2 HRH2 ARHGEF2	1.52e-04	860	96	13	GO:0097447
GeneOntologyCellularComponent	centrosome	ROCK2 PDE4B HDAC6 RBBP6 HIPK1 UBXN6 TRIOBP SORBS1 KAT2A CDC14B MTUS1 FBXO31	2.10e-04	770	96	12	GO:0005813
GeneOntologyCellularComponent	postsynapse	NCOA2 ROCK2 CACNA1A KIF21B CACNA1S PDE4B ANK3 CHRM5 SYNGAP1 ABI2 PLEKHA5 ARHGEF2 RAB4A	7.60e-04	1018	96	13	GO:0098794
Domain	PH	ROCK2 TRIOBP SYNGAP1 PLEKHM2 PLEKHA5 ARHGEF2 AGAP1	1.38e-04	229	92	7	PF00169
Domain	SPOC_C	DIDO1 SPEN	3.55e-04	6	92	2	IPR012921
Domain	SPOC	DIDO1 SPEN	3.55e-04	6	92	2	PF07744
Domain	PH	ROCK2 TRIOBP SYNGAP1 PLEKHM2 PLEKHA5 ARHGEF2 AGAP1	4.47e-04	278	92	7	SM00233
Domain	PH_DOMAIN	ROCK2 TRIOBP SYNGAP1 PLEKHM2 PLEKHA5 ARHGEF2 AGAP1	4.57e-04	279	92	7	PS50003
Domain	PH_domain	ROCK2 TRIOBP SYNGAP1 PLEKHM2 PLEKHA5 ARHGEF2 AGAP1	4.67e-04	280	92	7	IPR001849
Domain	VDCC_a1su_IQ	CACNA1A CACNA1S	4.96e-04	7	92	2	IPR014873
Domain	GPHH	CACNA1A CACNA1S	4.96e-04	7	92	2	PF16905
Domain	GPHH_dom	CACNA1A CACNA1S	4.96e-04	7	92	2	IPR031649
Domain	Ca_chan_IQ	CACNA1A CACNA1S	4.96e-04	7	92	2	SM01062
Domain	Ca_chan_IQ	CACNA1A CACNA1S	4.96e-04	7	92	2	PF08763
Domain	VDCCAlpha1	CACNA1A CACNA1S	1.05e-03	10	92	2	IPR002077
Domain	-	HDAC6 RBBP6 EXPH5 SPIRE1 DIDO1 NSD3 PHF2 RNF6	1.67e-03	449	92	8	3.30.40.10
Domain	Znf_RING/FYVE/PHD	HDAC6 RBBP6 EXPH5 SPIRE1 DIDO1 NSD3 PHF2 RNF6	1.92e-03	459	92	8	IPR013083
Domain	-	ROCK2 TRIOBP SYNGAP1 PLEKHM2 PLEKHA5 ARHGEF2 AGAP1	3.18e-03	391	92	7	2.30.29.30
Domain	RUN	SNX29 PLEKHM2	3.49e-03	18	92	2	SM00593
Domain	RUN	SNX29 PLEKHM2	3.89e-03	19	92	2	PS50826
Domain	RUN	SNX29 PLEKHM2	3.89e-03	19	92	2	PF02759
Domain	Run_dom	SNX29 PLEKHM2	3.89e-03	19	92	2	IPR004012
Domain	Zinc_finger_PHD-type_CS	DIDO1 NSD3 PHF2	4.05e-03	65	92	3	IPR019786
Domain	PH_dom-like	ROCK2 TRIOBP SYNGAP1 PLEKHM2 PLEKHA5 ARHGEF2 AGAP1	5.08e-03	426	92	7	IPR011993
Domain	TNFR_c6	TNFRSF10B TNFRSF1B	5.20e-03	22	92	2	PF00020
Domain	Znf_FYVE_PHD	SPIRE1 DIDO1 NSD3 PHF2	6.03e-03	147	92	4	IPR011011
Domain	PHD	DIDO1 NSD3 PHF2	6.05e-03	75	92	3	PF00628
Domain	Znf_PHD-finger	DIDO1 NSD3 PHF2	6.98e-03	79	92	3	IPR019787
Domain	TNFR	TNFRSF10B TNFRSF1B	7.22e-03	26	92	2	SM00208
Domain	Bromodomain_CS	KAT2A PBRM1	7.22e-03	26	92	2	IPR018359
Domain	DEATH	ANK3 TNFRSF10B	7.78e-03	27	92	2	SM00005
Domain	TNFR_NGFR_1	TNFRSF10B TNFRSF1B	8.94e-03	29	92	2	PS00652
Domain	TNFR_NGFR_2	TNFRSF10B TNFRSF1B	8.94e-03	29	92	2	PS50050
Domain	PHD	DIDO1 NSD3 PHF2	9.68e-03	89	92	3	SM00249
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SUPT20H RBBP6 MRM1 POLR2C TRIOBP ADGRG1 SPIRE1 DIDO1 ICE1 KAT2A NSD3 PHF2 LARP4B PBRM1 ABI2 SUPT6H TNRC6A ARHGEF2 EIF4G3 SPEN AGAP1	9.49e-10	1497	98	21	31527615
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	ROCK2 SP1 HDAC6 RBBP6 DIDO1 ANKLE2 LARP4B PBRM1 PLEKHA5 ARHGEF2 EIF4G3 SRRM2 SPEN	1.82e-09	503	98	13	16964243
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOA2 ROCK2 CACNA1A KIF21B PDE4B ANK3 TRIOBP DIDO1 SORBS1 SYNGAP1 PBRM1 ABI2 NISCH PLEKHA5 ARHGEF2 UNC79	1.20e-08	963	98	16	28671696
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZBTB2 SUPT20H HDAC6 RBBP6 POLR2C KAT2A TNFRSF10B SCEL NSD3 PHF2 LARP4B INTS14 PBRM1 MTUS1 TNRC6A CRNN SRRM2	1.42e-08	1116	98	17	31753913
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	PRUNE2 CACNA1S SP1 AFF2 ANK3 RBBP6 SYNGAP1 LARP4B USF3 EIF4G3 SPEN	3.88e-08	430	98	11	35044719
Pubmed	A human MAP kinase interactome.	SP1 SUPT20H ANK3 RBBP6 EXPH5 HIPK1 SORBS1 NSD3 USF3 TNRC6A PLEKHA5	1.33e-07	486	98	11	20936779
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIF21B TRIOBP SPIRE1 DIDO1 ICE1 ANKLE2 MTUS1 SUPT6H TNRC6A PLEKHA5 AGAP1	3.09e-07	529	98	11	14621295
Pubmed	Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ROCK2 EXPH5 HIPK1 ANKLE2 PHF2 ARHGEF2	4.64e-07	102	98	6	9734811
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	MCM7 NSD3 PHF2 PBRM1 ARHGEF2 SPEN	6.87e-07	109	98	6	33554859
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SUPT20H HDAC6 RBBP6 POLR2C SMURF1 TRIOBP DIDO1 NSD3 SYNGAP1 PHF2 SUPT6H ARHGEF2 SRRM2 SPEN	2.10e-06	1082	98	14	38697112
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HIPK1 SMURF1 SORBS1 KIRREL3 PLEKHM2 NISCH ULK1 SRRM2 SPEN	2.37e-06	407	98	9	12693553
Pubmed	Epilepsy- and intellectual disability-associated CYFIP2 interacts with both actin regulators and RNA-binding proteins in the neonatal mouse forebrain.	RBBP6 UBXN6 TRIOBP SORBS1 ABI2 LNPK	3.35e-06	143	98	6	32560809
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	NCOA2 SUPT20H RBBP6 HIPK1 POLR2C MCM7 SORBS1 SUPT6H TNRC6A SPEN	6.53e-06	588	98	10	38580884
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	CACNA1A HIPK1 SORBS1 SYNGAP1 LNPK ARHGEF2 EIF4G3 SRRM2	6.53e-06	347	98	8	17114649
Pubmed	Hypokalaemic periodic paralysis due to the CACNA1S R1239H mutation in a large African family.	CACNA1A CACNA1S	7.86e-06	2	98	2	17418573
Pubmed	Deletion of Ulk1 inhibits neointima formation by enhancing KAT2A/GCN5-mediated acetylation of TUBA/α-tubulin in vivo.	KAT2A ULK1	7.86e-06	2	98	2	33985412
Pubmed	Dido3-dependent HDAC6 targeting controls cilium size.	HDAC6 DIDO1	7.86e-06	2	98	2	24667272
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ANK3 ZNF174 POLR2C TRIOBP ANKLE2 CDC14B NSD3 PHF2 MTUS1 ABI2 TNRC6A ARHGEF2 SRRM2	7.98e-06	1049	98	13	27880917
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	NCOA2 PDE4B HDAC6 ANK3 POLG SMURF1 SPIRE1 DIDO1 ANKLE2 LARP4B INTS14 LNPK SZRD1	1.13e-05	1084	98	13	11544199
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NCOA2 SUPT20H HDAC6 ANK3 HIPK1 POLG POLR2C TRIOBP SORBS1 SYNGAP1 ASCL1 NISCH EIF4G3 AGAP1	1.48e-05	1285	98	14	35914814
Pubmed	DNA cloning using in vitro site-specific recombination.	UBL3 TRIOBP SORBS1 EPX MRPL18 INTS14 FBXO31 ULK1 ARHGEF2 RAB4A CAPN15	1.51e-05	794	98	11	11076863
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NCOA2 PRUNE2 ANK3 POLG SMURF1 TRIOBP ADGRG1 SPIRE1 CDC14B SNX29 PHF2 USF3 SUPT6H EIF4G3 AGAP1	1.79e-05	1489	98	15	28611215
Pubmed	TLX activates MASH1 for induction of neuronal lineage commitment of adult hippocampal neuroprogenitors.	SP1 ASCL1	2.35e-05	3	98	2	20599619
Pubmed	Relation of ADRB3, GEF, ROCK2 gene polymorphisms to clinical findings in overactive bladder.	ROCK2 ARHGEF2	2.35e-05	3	98	2	31802204
Pubmed	Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1.	SP1 TNFRSF10B	2.35e-05	3	98	2	14561739
Pubmed	Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation.	SP1 TNFRSF10B	2.35e-05	3	98	2	21167276
Pubmed	Placental DNA Methylation Adaptation to Maternal Glycemic Response in Pregnancy.	PDE4B TNFRSF1B	2.35e-05	3	98	2	29752424
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ROCK2 ANK3 TRIOBP ANKLE2 ABI2 NISCH PLEKHA5 AGAP1	2.63e-05	421	98	8	36976175
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	NCOA2 ROCK2 AFF2 RBBP6 EXPH5 SPEN	2.84e-05	208	98	6	33230847
Pubmed	The Repeat Expansion Diseases: The dark side of DNA repair.	CACNA1A AFF2 FXN	3.69e-05	23	98	3	26002199
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	SP1 HDAC6 AFF2 PCDHA12 EPX LTBP2 SPEN	4.21e-05	329	98	7	17474147
Pubmed	Novel transcription factors in human CD34 antigen-positive hematopoietic cells.	SUPT20H DIDO1	4.70e-05	4	98	2	12070015
Pubmed	DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells.	KAT2A TNFRSF10B	4.70e-05	4	98	2	25770212
Pubmed	Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries.	ANK3 PBRM1	4.70e-05	4	98	2	21037240
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	NCOA2 CACNA1A SP1 HIPK1 PLEKHM2 SRRM2	5.34e-05	233	98	6	37704626
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	RBBP6 MCM7 LARP4B PBRM1 SUPT6H TNRC6A SPEN UNC79	5.62e-05	469	98	8	27634302
Pubmed	MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity.	HDAC6 RBBP6 LARP4B MTUS1 ARHGEF2	6.86e-05	150	98	5	22678362
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SP1 SUPT20H RBBP6 POLR2C DIDO1 KAT2A NSD3 PHF2 INTS14 PBRM1 SUPT6H SRRM2 SPEN	7.04e-05	1294	98	13	30804502
Pubmed	RNF138 inhibits late inflammatory gene transcription through degradation of SMARCC1 of the SWI/SNF complex.	PBRM1 EIF4G3 SRRM2	7.52e-05	29	98	3	36800290
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	ANK3 RBBP6 DIDO1 ICE1 PLEKHA5 SRRM2 SPEN	7.54e-05	361	98	7	26167880
Pubmed	RNA polymerase II subunit 3 is retained in the cytoplasm by its interaction with HCR, the psoriasis vulgaris candidate gene product.	SP1 POLR2C	7.82e-05	5	98	2	16141233
Pubmed	ZBTB2 increases PDK4 expression by transcriptional repression of RelA/p65.	SP1 ZBTB2	7.82e-05	5	98	2	25609694
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ROCK2 PRUNE2 ZBTB2 EXPH5 PHF2 LARP4B USF3 LNPK	7.95e-05	493	98	8	15368895
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	MCM7 ANKLE2 PBRM1 SUPT6H ARMC5 TNRC6A PLEKHA5 ARHGEF2 SRRM2	8.30e-05	639	98	9	23443559
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	KIF21B SUPT20H ANK3 EXPH5 MRM1 SORBS1 SYNGAP1 PLEKHA5	8.40e-05	497	98	8	36774506
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CACNA1A UBE2J1 ANK3 TRIOBP SORBS1 ANKLE2 SYNGAP1 LARP4B ABI2 TNRC6A LNPK EIF4G3	8.75e-05	1139	98	12	36417873
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	ROCK2 RBBP6 MRM1 DIDO1 LARP4B SUPT6H TNRC6A EIF4G3 SRRM2 SPEN	9.53e-05	807	98	10	22681889
Pubmed	Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes.	NCOA2 ZBTB2 RBBP6 SRRM2	1.01e-04	85	98	4	16051665
Pubmed	The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function.	CACNA1S LARP4B PBRM1	1.11e-04	33	98	3	22357600
Pubmed	ICAP-1 monoubiquitylation coordinates matrix density and rigidity sensing for cell migration through ROCK2-MRCKα balance.	ROCK2 SMURF1	1.17e-04	6	98	2	28049720
Pubmed	USP1 (ubiquitin specific peptidase 1) targets ULK1 and regulates its cellular compartmentalization and autophagy.	HDAC6 ULK1	1.17e-04	6	98	2	30335599
Pubmed	Role of Unc51.1 and its binding partners in CNS axon outgrowth.	SYNGAP1 ULK1	1.17e-04	6	98	2	15014045
Pubmed	Akhirin regulates the proliferation and differentiation of neural stem cells/progenitor cells at neurogenic niches in mouse brain.	VIT ASCL1	1.17e-04	6	98	2	31943155
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	UBL3 SORBS1 LARP4B TNRC6A PLEKHA5 ARHGEF2 SZRD1 AGAP1	1.41e-04	536	98	8	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	UBL3 SORBS1 LARP4B TNRC6A PLEKHA5 ARHGEF2 SZRD1 AGAP1	1.45e-04	538	98	8	10512203
Pubmed	The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.	SUPT20H RBBP6 DIDO1 KAT2A LARP4B PBRM1	1.49e-04	281	98	6	24163370
Pubmed	Mast cell-derived histamine mediates cystitis pain.	HRH2 TNFRSF1B	1.64e-04	7	98	2	18461160
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 ANK3 RBBP6 DIDO1 MCM7 NSD3 PLEKHA5 SPEN	1.66e-04	549	98	8	38280479
Pubmed	BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A.	RBBP6 FXN LARP4B MRPL18 SUPT6H NISCH ARHGEF2	1.89e-04	419	98	7	33001583
Pubmed	Distinct gene loci control the host response to influenza H1N1 virus infection in a time-dependent manner.	SORBS1 RNF6	2.18e-04	8	98	2	22905720
Pubmed	Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.	SP1 HDAC6	2.18e-04	8	98	2	16288017
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	RBBP6 MCM7 PBRM1 RNF6 SPEN	2.34e-04	195	98	5	19454010
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	POLR2C MCM7 LARP4B PBRM1 SUPT6H NISCH ARHGEF2	2.54e-04	440	98	7	34244565
Pubmed	ATAC and SAGA co-activator complexes utilize co-translational assembly, but their cellular localization properties and functions are distinct.	SUPT20H POLR2C KAT2A	2.64e-04	44	98	3	37682711
Pubmed	Functional proteomics mapping of a human signaling pathway.	ANK3 RBBP6 EXPH5 HIPK1 SMURF1 FAM161B ANKLE2 PBRM1	2.73e-04	591	98	8	15231748
Pubmed	International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.	CACNA1A CACNA1S	2.79e-04	9	98	2	16382099
Pubmed	Genome wide association study of age at menarche in the Japanese population.	KIRREL3 AGAP1	2.79e-04	9	98	2	23667675
Pubmed	UV-Induced RPA1 Acetylation Promotes Nucleotide Excision Repair.	HDAC6 KAT2A	2.79e-04	9	98	2	28854355
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	POLG SPIRE1 ICE1 KAT2A CDC14B NSD3 PLEKHM2 NISCH ULK1 ARHGEF2 SPEN	2.85e-04	1105	98	11	35748872
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	ROCK2 ANK3 SPIRE1 MCM7 ANKLE2 NISCH DACT3 CRNN AGMAT PLEKHA5 LNPK AGAP1	3.43e-04	1321	98	12	27173435
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ROCK2 SP1 HDAC6 RBBP6 DIDO1 MYO3A ARHGEF2 SRRM2 SPEN	3.45e-04	774	98	9	15302935
Pubmed	A transcriptional inhibitor targeted by the atypical orphan nuclear receptor SHP.	NCOA2 KAT2A	3.48e-04	10	98	2	11964378
Pubmed	AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.	CHRM5 AGAP1	3.48e-04	10	98	2	20664521
Pubmed	The genetic aetiology of late-onset chronic progressive cerebellar ataxia. A population-based study.	CACNA1A FXN	3.48e-04	10	98	2	19259763
Pubmed	Graft-versus-leukemia (GVL) against mouse blast-crisis chronic myelogenous leukemia (BC-CML) and chronic-phase chronic myelogenous leukemia (CP-CML): shared mechanisms of T cell killing, but programmed death ligands render CP-CML and not BC-CML GVL resistant.	TNFRSF10B TNFRSF1B	3.48e-04	10	98	2	21768400
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	SORBS1 SYNGAP1 TNRC6A ARHGEF2 AGAP1	3.91e-04	218	98	5	33378226
Pubmed	De novo phosphorylation of H2AX by WSTF regulates transcription-coupled homologous recombination repair.	POLR2C SUPT6H	4.25e-04	11	98	2	31045206
Pubmed	Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects.	SUPT20H KAT2A	4.25e-04	11	98	2	24051374
Pubmed	Adrenocorticotropic hormone-mediated signaling cascades coordinate a cyclic pattern of steroidogenic factor 1-dependent transcriptional activation.	NCOA2 KAT2A	4.25e-04	11	98	2	16109736
Pubmed	TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression.	MCM7 SUPT6H	5.09e-04	12	98	2	30479348
Pubmed	Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential.	TNFRSF10B TNFRSF1B	5.09e-04	12	98	2	29436413
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	HDAC6 RBBP6 POLR2C LARP4B SUPT6H SRRM2	5.42e-04	358	98	6	32460013
Pubmed	MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.	MTUS1 PLEKHA5 ARHGEF2	5.68e-04	57	98	3	29089450
Pubmed	ELOF1 is a transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation.	POLR2C PHF2 SUPT6H	6.29e-04	59	98	3	34108663
Pubmed	Human transcription factor protein interaction networks.	NCOA2 SP1 SUPT20H RBBP6 DIDO1 KAT2A PHF2 LARP4B PBRM1 TNRC6A SRRM2 SPEN	6.88e-04	1429	98	12	35140242
Pubmed	Class III myosins shape the auditory hair bundles by limiting microvilli and stereocilia growth.	TRIOBP MYO3A	7.00e-04	14	98	2	26754646
Pubmed	Control of HIV latency by epigenetic and non-epigenetic mechanisms.	SP1 POLR2C	7.00e-04	14	98	2	22211660
Pubmed	Retinoic acid selectively inhibits death of basal vomeronasal neurons during late stage of neural circuit formation.	PDE4B KIRREL3	7.00e-04	14	98	2	19519663
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	ROCK2 ANK3 TNFRSF10B ABI2 PLEKHA5 AGAP1	7.10e-04	377	98	6	38117590
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	NCOA2 ZBTB2 HDAC6 HIPK1 MRPL18 ABI2 NISCH ARHGEF2 SPEN	7.16e-04	857	98	9	25609649
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	EXPH5 SPIRE1 SORBS1 NSD3 MTUS1 PLEKHA5 ARHGEF2 EIF4G3 SRRM2	7.40e-04	861	98	9	36931259
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	ANK3 TRIOBP SNX29 PLEKHA5 ARHGEF2	7.40e-04	251	98	5	29778605
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	ROCK2 PDE4B ANK3 SORBS1 SYNGAP1	7.40e-04	251	98	5	27507650
Pubmed	The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation.	MCM7 LARP4B MRPL18 PBRM1 SUPT6H	7.67e-04	253	98	5	29911972
Pubmed	Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons.	CACNA1A CACNA1S	8.06e-04	15	98	2	20188150
Pubmed	The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.	SP1 POLR2C	8.06e-04	15	98	2	8800208
Pubmed	TRIM28 functions as the SUMO E3 ligase for PCNA in prevention of transcription induced DNA breaks.	POLR2C MCM7	8.06e-04	15	98	2	32900933
Pubmed	Differential neuronal targeting of a new and two known calcium channel β4 subunit splice variants correlates with their regulation of gene expression.	CACNA1A CACNA1S	8.06e-04	15	98	2	24453333
Pubmed	HIV latency.	SP1 POLR2C	8.06e-04	15	98	2	22229121
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ROCK2 UBE2J1 HDAC6 ANK3 THSD1 ANKLE2 PLEKHA5 EIF4G3	8.93e-04	708	98	8	39231216
Interaction	H3-4 interactions	NCOA2 SUPT20H DIDO1 MCM7 KAT2A NSD3 PHF2 USF3 PBRM1 TNRC6A PLEKHA5 RAB4A	1.16e-06	448	94	12	int:H3-4
Interaction	TWIST1 interactions	HDAC6 MCM7 NSD3 PHF2 PBRM1 ARHGEF2 SPEN	1.48e-05	170	94	7	int:TWIST1
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ROCK2 TRIOBP PLEKHM2 PLEKHA5 ARHGEF2 AGAP1	8.80e-05	206	64	6	682
GeneFamily	Lysine acetyltransferases\|ATAC complex\|SAGA complex\|GCN5 related N-acetyltransferases	SUPT20H KAT2A	1.62e-03	17	64	2	1059
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA2 KAT2A	1.62e-03	17	64	2	486
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	ROCK2 KIF21B POLG ADGRG1 DIDO1 MCM7 KAT2A TNFRSF10B SNX29 CD300C PLEKHM2 STRADA NISCH ULK1 TNFRSF1B SRRM2 SPEN	3.43e-08	905	97	17	M40865
Coexpression	GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN	ROCK2 PDE4B HIPK1 ANKLE2 PARP6 PHF2 NISCH TNRC6A	2.05e-07	167	97	8	M361
Coexpression	GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP	KIF21B HIPK1 MCM7 SNX29 CD300C PLEKHM2 EIF4G3	4.89e-06	180	97	7	M6718
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP	ZBTB2 PDE4B UBL3 SMURF1 USF3 TNRC6A SPEN	7.47e-06	192	97	7	M8272
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	PRUNE2 ANK3 SNX29 TNRC6A PLEKHA5 SRRM2 AGAP1	1.86e-05	221	97	7	M39222
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 ANK3 ADGRG1 SNX29 PLEKHA5 AGAP1	4.12e-06	191	98	6	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 ANK3 ADGRG1 SNX29 PLEKHA5 AGAP1	4.12e-06	191	98	6	1c1d13144259b998d4a0e85142f7afef2ef1e63f
Drug	prazosin hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA	SP1 SUPT20H ANK3 ZNF174 MRM1 KAT2A RNF6 PLEKHM2 SZRD1	1.40e-07	197	95	9	826_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A	NCOA2 ROCK2 SP1 MRM1 POLG LARP4B RNF6 LTBP2	1.55e-06	194	95	8	5075_DN
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A	AFF2 MRM1 POLG POLR2C TRIOBP CDC14B NSD3 EIF4G3	1.74e-06	197	95	8	4761_DN
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A	NCOA2 ROCK2 UBE2J1 EXPH5 POLR2C ADGRG1 THSD1 NSD3	1.81e-06	198	95	8	7500_DN
Drug	geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A	NCOA2 UBE2J1 AFF2 SORBS1 MRPL18 LTBP2 ARHGEF2	1.18e-05	183	95	7	6946_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	MRM1 TRIOBP KAT2A NSD3 SUPT6H AGMAT CAPN15	1.66e-05	193	95	7	1284_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; SKMEL5; HG-U133A	UBE2J1 PDE4B HDAC6 UBL3 RBBP6 MRM1 POLG	1.66e-05	193	95	7	629_DN
Drug	Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A	HDAC6 EXPH5 KAT2A TNFRSF10B SUPT6H SZRD1 CAPN15	1.66e-05	193	95	7	7232_DN
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	SUPT20H ANK3 ZNF174 POLG CHRM5 NSD3 RNF6	1.78e-05	195	95	7	7539_DN
Drug	Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; HL60; HT_HG-U133A	SP1 POLR2C KAT2A NSD3 RNF6 AGMAT EIF4G3	1.78e-05	195	95	7	2966_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	NCOA2 SP1 POLR2C SMURF1 EPX LARP4B AGMAT	1.78e-05	195	95	7	2208_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A_EA	NCOA2 ROCK2 TRIOBP TNFRSF10B LARP4B RNF6 PLEKHM2	1.78e-05	195	95	7	989_DN
Drug	Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; PC3; HT_HG-U133A	UBE2J1 SUPT20H ANK3 ZNF174 HIPK1 TNFRSF10B ABI2	1.83e-05	196	95	7	7320_DN
Drug	Niridazole [61-57-4]; Up 200; 18.6uM; HL60; HT_HG-U133A	SP1 MRM1 SMURF1 CDC14B LARP4B PLEKHM2 LTBP2	1.83e-05	196	95	7	2440_UP
Drug	Acenocoumarol [152-72-7]; Down 200; 11.4uM; HL60; HG-U133A	RBBP6 MRM1 POLR2C TRIOBP PLEKHM2 EIF4G3 SZRD1	1.90e-05	197	95	7	1394_DN
Drug	Debrisoquin sulfate [581-88-4]; Up 200; 9uM; HL60; HG-U133A	ROCK2 UBE2J1 ANK3 MRM1 POLG ABI2 SZRD1	1.90e-05	197	95	7	1591_UP
Drug	Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A	ROCK2 EXPH5 KAT2A CDC14B NSD3 RNF6 PLEKHM2	1.90e-05	197	95	7	3338_DN
Drug	Delsoline [509-18-2]; Up 200; 8.6uM; HL60; HT_HG-U133A	ROCK2 CACNA1A SMURF1 THSD1 ST7L CDC14B CRNN	1.90e-05	197	95	7	2513_UP
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	HDAC6 ZNF174 POLG DIDO1 LARP4B SUPT6H CAPN15	1.90e-05	197	95	7	6974_DN
Drug	Tomatidine [77-59-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ROCK2 HDAC6 POLR2C MTUS1 SUPT6H SRRM2 CAPN15	1.96e-05	198	95	7	7166_DN
Drug	5140203; Up 200; 15uM; MCF7; HT_HG-U133A_EA	NCOA2 ROCK2 ANK3 EXPH5 LARP4B RNF6 ARHGEF2	1.96e-05	198	95	7	908_UP
Drug	Gabazine [105538-73-6]; Down 200; 10.8uM; HL60; HT_HG-U133A	UBL3 EXPH5 POLG TRIOBP TNFRSF10B PLEKHM2 PLEKHA5	1.96e-05	198	95	7	1316_DN
Drug	Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	NCOA2 AFF2 EXPH5 POLR2C SMURF1 MTUS1 SRRM2	1.96e-05	198	95	7	7200_DN
Drug	Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A	HDAC6 ZNF174 POLR2C TNFRSF10B LARP4B RNF6 SUPT6H	1.96e-05	198	95	7	3219_DN
Drug	Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	NCOA2 ROCK2 ZNF174 POLG POLR2C THSD1 ARHGEF2	1.96e-05	198	95	7	4733_DN
Drug	AC1L1JG6	ROCK2 CACNA1A CACNA1S	2.48e-05	14	95	3	CID000005026
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PHF2 LARP4B RNF6 SRRM2 CAPN15	6.52e-05	164	95	6	4388_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	SMURF1 TRIOBP DIDO1 PHF2 INTS14 SRRM2	9.05e-05	174	95	6	3993_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 UBE2J1 TRIOBP PHF2 INTS14 SRRM2	9.34e-05	175	95	6	7387_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 MRM1 POLG DIDO1 PHF2 SRRM2	9.64e-05	176	95	6	2639_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; HL60; HT_HG-U133A	KIF21B UBE2J1 MRM1 POLR2C KAT2A AGMAT	1.03e-04	178	95	6	2977_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	RBBP6 EXPH5 CDC14B SRRM2 SPEN SZRD1	1.03e-04	178	95	6	3998_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 MRM1 DIDO1 KAT2A PHF2 SRRM2	1.03e-04	178	95	6	4710_DN
Drug	trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A	POLG ADGRG1 PHF2 PLEKHM2 ASCL1 CAPN15	1.06e-04	179	95	6	332_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 UBE2J1 TRIOBP PHF2 INTS14 SRRM2	1.06e-04	179	95	6	4483_DN
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A	NCOA2 RBBP6 EXPH5 TRIOBP PLEKHA5 EIF4G3	1.12e-04	181	95	6	1791_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	NCOA2 ROCK2 DIDO1 LARP4B PLEKHA5 AGAP1	1.19e-04	183	95	6	7498_DN
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	EXPH5 HIPK1 TNFRSF10B LARP4B SRRM2 SPEN	1.27e-04	185	95	6	1673_DN
Drug	Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; HL60; HT_HG-U133A	PDE4B EPX RNF6 MTUS1 ASCL1 CRNN	1.34e-04	187	95	6	3037_UP
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	ZNF174 HIPK1 UBXN6 ADGRG1 LTBP2 SRRM2	1.47e-04	190	95	6	4362_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	NCOA2 EXPH5 HIPK1 THSD1 CDC14B NSD3	1.51e-04	191	95	6	4279_DN
Drug	17-AAG; Down 200; 1uM; HL60; HT_HG-U133A	KIF21B UBE2J1 EXPH5 MRM1 POLR2C PLEKHM2	1.51e-04	191	95	6	2685_DN
Drug	Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A	UBE2J1 POLG TRIOBP CDC14B LARP4B SRRM2	1.55e-04	192	95	6	7427_DN
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; HL60; HT_HG-U133A	ROCK2 MRM1 POLG POLR2C TNFRSF10B RNF6	1.60e-04	193	95	6	1852_DN
Drug	Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; HL60; HG-U133A	ROCK2 POLR2C UBXN6 EPX ABI2 SZRD1	1.60e-04	193	95	6	1378_DN
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; HL60; HG-U133A	ROCK2 HIPK1 MRM1 ABI2 SZRD1 CAPN15	1.60e-04	193	95	6	1363_DN
Drug	rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; PC3; HT_HG-U133A	ROCK2 SUPT20H DIDO1 TNFRSF10B SCEL ULK1	1.60e-04	193	95	6	5932_UP
Drug	Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; HL60; HT_HG-U133A	ROCK2 PDE4B ANK3 LARP4B LTBP2 SRRM2	1.60e-04	193	95	6	2412_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	NCOA2 ROCK2 CACNA1A POLG NSD3 AGMAT	1.60e-04	193	95	6	2721_DN
Drug	Iopromide [73334-07-3]; Up 200; 5uM; MCF7; HT_HG-U133A	NCOA2 SUPT20H EXPH5 NSD3 ARHGEF2 SZRD1	1.64e-04	194	95	6	3481_UP
Drug	retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A	PDE4B SMURF1 TNFRSF10B THSD1 SUPT6H SRRM2	1.64e-04	194	95	6	1211_DN
Drug	Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ROCK2 UBE2J1 SUPT20H ZNF174 SUPT6H EIF4G3	1.64e-04	194	95	6	7406_DN
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA	UBE2J1 ZNF174 DIDO1 TNFRSF10B CDC14B NSD3	1.64e-04	194	95	6	1061_UP
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA	UBE2J1 HDAC6 TRIOBP DIDO1 CDC14B SRRM2	1.64e-04	194	95	6	990_DN
Drug	Biotin [58-85-5]; Down 200; 16.4uM; PC3; HT_HG-U133A	CACNA1A AFF2 SMURF1 TRIOBP CDC14B LARP4B	1.69e-04	195	95	6	6689_DN
Drug	Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; PC3; HT_HG-U133A	SUPT20H RBBP6 SORBS1 NSD3 MYO3A EIF4G3	1.69e-04	195	95	6	5760_UP
Drug	Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; PC3; HT_HG-U133A	ANK3 SCEL MTUS1 NISCH SZRD1 CAPN15	1.69e-04	195	95	6	2102_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	SP1 EXPH5 MTUS1 ABI2 PLEKHA5 SRRM2	1.69e-04	195	95	6	2566_UP
Drug	Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	NCOA2 HDAC6 EXPH5 PHF2 ULK1 EIF4G3	1.69e-04	195	95	6	7225_DN
Drug	STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A	ZNF174 HIPK1 SMURF1 TNFRSF10B CDC14B SRRM2	1.69e-04	195	95	6	6561_UP
Drug	Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	AFF2 POLR2C SMURF1 NSD3 SRRM2 CAPN15	1.69e-04	195	95	6	4019_DN
Drug	Ethionamide [536-33-4]; Up 200; 24uM; PC3; HT_HG-U133A	SUPT20H POLR2C EPX NSD3 RNF6 ARHGEF2	1.69e-04	195	95	6	4593_UP
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ROCK2 MRM1 TRIOBP RNF6 SUPT6H SZRD1	1.74e-04	196	95	6	1708_DN
Drug	Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A	ANK3 MRM1 POLR2C TRIOBP KAT2A SUPT6H	1.74e-04	196	95	6	5293_DN
Drug	Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; PC3; HG-U133A	NCOA2 HIPK1 CDC14B AGMAT PLEKHA5 SPEN	1.74e-04	196	95	6	1948_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A	AFF2 POLR2C UBXN6 CDC14B NSD3 EIF4G3	1.74e-04	196	95	6	4749_DN
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A	CACNA1A SP1 MRM1 POLR2C THSD1 NSD3	1.74e-04	196	95	6	3739_DN
Drug	Flurandrenolide [1524-88-5]; Up 200; 9.2uM; PC3; HT_HG-U133A	CACNA1A SP1 SUPT20H ST7L CDC14B CD300C	1.74e-04	196	95	6	7378_UP
Drug	Levonordefrin [829-74-3]; Up 200; 21.8uM; MCF7; HT_HG-U133A	NCOA2 ROCK2 UBE2J1 SORBS1 EPX LTBP2	1.74e-04	196	95	6	7208_UP
Drug	Terazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; HL60; HT_HG-U133A	NCOA2 ROCK2 HDAC6 SMURF1 ASCL1 SUPT6H	1.74e-04	196	95	6	2530_UP
Drug	17-AAG; Up 200; 1uM; PC3; HT_HG-U133A	PDE4B HDAC6 AFF2 DIDO1 SORBS1 PARP6	1.74e-04	196	95	6	5919_UP
Drug	Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; PC3; HT_HG-U133A	NCOA2 ROCK2 UBE2J1 ANK3 LTBP2 EIF4G3	1.74e-04	196	95	6	7257_DN
Drug	Diethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A	PRUNE2 PDE4B SORBS1 SCEL PARP6 RNF6	1.74e-04	196	95	6	4547_UP
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A	NCOA2 TNFRSF10B MTUS1 SUPT6H ULK1 CAPN15	1.74e-04	196	95	6	6309_DN
Drug	estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A	PDE4B POLR2C SORBS1 EPX PARP6 HRH2	1.74e-04	196	95	6	5910_UP
Drug	Suramin sodium salt; Down 200; 10uM; MCF7; HT_HG-U133A	NCOA2 ROCK2 UBE2J1 TNFRSF10B SNX29 RNF6	1.74e-04	196	95	6	7496_DN
Drug	Pinacidil [85371-64-8]; Down 200; 16.4uM; HL60; HT_HG-U133A	TRIOBP NSD3 PLEKHM2 ABI2 SUPT6H CAPN15	1.74e-04	196	95	6	2406_DN
Drug	Suxibuzone [27470-51-5]; Down 200; 9.2uM; PC3; HT_HG-U133A	HDAC6 ANK3 POLR2C CDC14B MTUS1 SZRD1	1.74e-04	196	95	6	5806_DN
Drug	Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A	UBXN6 DIDO1 TNFRSF10B LARP4B PBRM1 AGMAT	1.78e-04	197	95	6	6229_DN
Drug	Ifosfamide [3778-73-2]; Down 200; 15.4uM; MCF7; HT_HG-U133A	HDAC6 MRM1 SMURF1 KAT2A CDC14B SRRM2	1.78e-04	197	95	6	6279_DN
Drug	Tolbutamide [64-77-7]; Up 200; 14.8uM; PC3; HT_HG-U133A	SP1 ADGRG1 KAT2A CDC14B RNF6 MTUS1	1.78e-04	197	95	6	4540_UP
Drug	Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A	ROCK2 ANK3 KAT2A CDC14B SZRD1 CAPN15	1.78e-04	197	95	6	7201_DN
Drug	Levonordefrin [829-74-3]; Down 200; 21.8uM; MCF7; HT_HG-U133A	HDAC6 MRM1 KAT2A EIF4G3 SRRM2 CAPN15	1.78e-04	197	95	6	7208_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	DIDO1 MCM7 FXN RNF6 AGMAT LTBP2	1.78e-04	197	95	6	2375_DN
Drug	Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A	ROCK2 HIPK1 THSD1 LARP4B MTUS1 SUPT6H	1.78e-04	197	95	6	1183_DN
Drug	Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; HL60; HT_HG-U133A	PDE4B ZNF174 MRM1 TRIOBP RNF6 CAPN15	1.78e-04	197	95	6	1846_DN
Drug	Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A	NCOA2 PRUNE2 AFF2 UBXN6 NSD3 PBRM1	1.78e-04	197	95	6	7358_UP
Drug	Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; PC3; HT_HG-U133A	SP1 POLG TRIOBP THSD1 MTUS1 LTBP2	1.78e-04	197	95	6	5044_DN
Drug	Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; HL60; HG-U133A	ROCK2 UBE2J1 SUPT20H POLR2C NSD3 PLEKHM2	1.78e-04	197	95	6	1600_DN
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	ROCK2 AFF2 POLR2C CD300C NSD3 PARP6	1.78e-04	197	95	6	6867_DN
Drug	Bezafibrate [41859-67-0]; Up 200; 11uM; PC3; HT_HG-U133A	CACNA1A AFF2 SNX29 CD300C PLEKHM2 ASCL1	1.78e-04	197	95	6	6653_UP
Drug	Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; HL60; HG-U133A	PDE4B MRM1 POLR2C DIDO1 TNFRSF10B SZRD1	1.78e-04	197	95	6	2022_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A	UBE2J1 PDE4B POLR2C PHF2 PLEKHM2 SRRM2	1.78e-04	197	95	6	1240_DN
Drug	Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A	UBE2J1 ZNF174 POLR2C TRIOBP TNFRSF10B NSD3	1.83e-04	198	95	6	7443_DN
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	SP1 POLR2C CDC14B LARP4B PLEKHM2 CAPN15	1.83e-04	198	95	6	6991_DN
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A	SP1 ZNF174 THSD1 LARP4B RNF6 PLEKHM2	1.83e-04	198	95	6	2297_DN
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	NCOA2 SP1 ZNF174 POLR2C SMURF1 INTS14	1.83e-04	198	95	6	1491_DN
Drug	Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; HL60; HG-U133A	POLG DIDO1 THSD1 CD300C NSD3 SUPT6H	1.83e-04	198	95	6	1983_UP
Drug	Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A	ZNF174 POLR2C CDC14B LARP4B RNF6 EIF4G3	1.83e-04	198	95	6	7023_DN
Drug	Bacitracin [1405-87-4]; Up 200; 2.8uM; HL60; HT_HG-U133A	ANK3 EXPH5 SMURF1 ST7L EPX CDC14B	1.83e-04	198	95	6	3109_UP
Disease	skin conductance response frequency, electrodermal activity measurement	RBBP6 TNRC6A	3.20e-05	3	97	2	EFO_0006866, EFO_0006869
Disease	electrodermal activity measurement	RBBP6 TNRC6A	3.20e-05	3	97	2	EFO_0006866
Disease	thrombospondin type-1 domain-containing protein 1 measurement	THSD1 KIRREL3	1.06e-04	5	97	2	EFO_0802131
Disease	Esophageal carcinoma	RNF6 CRNN	2.22e-04	7	97	2	C0152018
Disease	Withdrawal Symptoms	SMURF1 CHRM5 HRH2	9.32e-04	58	97	3	C0087169
Disease	Drug Withdrawal Symptoms	SMURF1 CHRM5 HRH2	9.32e-04	58	97	3	C0086189
Disease	Substance Withdrawal Syndrome	SMURF1 CHRM5 HRH2	9.32e-04	58	97	3	C0038587
Disease	Nonorganic psychosis	SP1 ANK3 PBRM1	1.54e-03	69	97	3	C0349204
Disease	age at first sexual intercourse measurement	PDE4B SNX29 PHF2 TNRC6A PLEKHA5 UNC79	1.68e-03	383	97	6	EFO_0009749
Disease	age at onset, smoking initiation	NCOA2 SCEL	1.76e-03	19	97	2	EFO_0004847, EFO_0005670
Disease	red blood cell density measurement	NRN1L SP1 SORBS1 EPX LARP4B PBRM1 STRADA EIF4G3 AGAP1	2.47e-03	880	97	9	EFO_0007978
Disease	thyroxine measurement	DIDO1 SNX29 KIRREL3	2.62e-03	83	97	3	EFO_0005130
Disease	neuroticism measurement, cognitive function measurement	PCDHA12 SNX29 SYNGAP1 TNRC6A LNPK EIF4G3 AGAP1	2.68e-03	566	97	7	EFO_0007660, EFO_0008354
Disease	depressive symptom measurement	CACNA1A PHF2 KIRREL3 ASCL1 LNPK EIF4G3	2.86e-03	426	97	6	EFO_0007006
Disease	response to venlafaxine	POLG AGAP1	3.05e-03	25	97	2	EFO_0006328

Protein segments in the cluster

Peptide	Gene	Start	Entry
EVPQNLSASRPQDRQ	TRBV30	76	A0A0K0K1B3
RPLVVDPQENRNNNT	CACNA1A	821	O00555
RQPSAPQTLRQRQHT	BRWD1-AS2	46	P59051
IKNRQNAARNNSPPT	ANKLE2	651	Q86XL3
RRNNNRNNSSGRVPT	AGAP1	841	Q9UPQ3
IRSSTQQDPRRRDPQ	CDC14B	31	O60729
KPPNTRENNSSRRAN	AFF2	891	P51816
SSQRDRNGNQLRSPQ	ARHGEF2	721	Q92974
LRQRRDPNGASPTSQ	ARMC5	331	Q96C12
QSPVRTASVNQRNRT	ABI2	226	Q9NYB9
NRPQRSSRSRQNWPK	CD300C	206	Q08708
QLRSPRRAQAPNAQE	RAB4A	201	P20338
PARPGLSQQQRASQR	KAT2A	76	Q92830
SSTLQNNPVPRSRRE	CAPN15	236	O75808
TPRRASSNQRGLNQI	FXN	51	Q16595
RERAAQQQQPSASPR	PBRM1	1441	Q86U86
QRSPPRCSQEANSRK	LILRA4	471	P59901
ESRAQNRRLLPDAPN	PIP5KL1	316	Q5T9C9
QTQDPSRNELQVPRS	H2AP	16	O75409
DNRNPSADRAVSPQR	MTUS1	741	Q9ULD2
PTSQERSSNPAPRRQ	HIPK1	1056	Q86Z02
RSSNPAPRRQQAFVA	HIPK1	1061	Q86Z02
NQRTSPRAPANIQVS	FNDC7	196	Q5VTL7
SPQTRQAGQTRTRIQ	LARP4B	451	Q92615
RVQATFRNADAPSPQ	FBXO31	511	Q5XUX0
RSNTLRERSQQAPPN	PCDHGC5	811	Q9Y5F6
RSAPSCPQNKNRVRN	EPX	286	P11678
QLPPLSQRQSERART	PDE4B	51	Q07343
PRNDRNVFSRLTSNQ	KIF21B	1246	O75037
ASQLSRTQSREPRQQ	HRH2	321	P25021
PASDPSDGQRRRQQQ	POLG	31	P54098
SSNRANPQPRTATRT	FAM161B	336	Q96MY7
FSQISDDRRNPQSPN	EXPH5	631	Q8NEV8
DDRRNPQSPNLQNPT	EXPH5	636	Q8NEV8
NQTTEMRPERQPQTR	CRNN	201	Q9UBG3
QRSRDPGMVRSPQNQ	MCM7	111	P33993
RSPQAFRGQSPNKRN	RBBP6	771	Q7Z6E9
NPQSRPEARSDAGRQ	ICE1	1341	Q9Y2F5
RQNSVRQRPPDASPS	DACT3	281	Q96B18
SLPQQQPAAVARRNE	ASCL1	111	P50553
PRTNPLARANTNNAN	CACNA1S	1651	Q13698
ATQNQRSESNRFPLP	INTS14	131	Q96SY0
TQSQPQRTFPEIQRR	IGHD	46	P01880
AAPSQPNSQIRQNIR	DIDO1	661	Q9BTC0
ASRRPSAAPASQQLQ	ADGRG1	196	Q9Y653
RQQAAASQSPSLPER	ANK3	2001	Q12955
QSRRVQPPAQTRRST	LTBP2	111	Q14767
SQNSDPSRPLQRRMQ	KIRREL3	761	Q8IZU9
QDSTTTRQRRSRQNP	HDAC6	6	Q9UBN7
PTSASLTQRQRQRQQ	CCDC201	106	A0A1B0GTI1
PIERLQRRNSNPSAE	C4orf54	1336	D6RIA3
DSQNLNSRRSPVPAQ	EIF4G3	486	O43432
PQTRSIQSRFLQSRN	PARP6	546	Q2NL67
SQQRRQRVCSAESPP	PCDHA12	751	Q9UN75
STRSPTQRQNPFNEE	PLEKHM2	261	Q8IWE5
ESLQQEARQAPRPNN	NRN1L	96	Q496H8
TRISQPEDSRQPNNV	SZRD1	121	Q7Z422
QRNPDARPSASTLLN	STRADA	361	Q7RTN6
SRGQPRETRNVEPQS	SNX29	796	Q8TEQ0
TSPQANEQSVTPQRR	SRRM2	856	Q9UQ35
TQRRPSASSPNNNTA	PHF2	1051	O75151
PPQSLQQSSRNRISS	PRUNE2	1011	Q8WUY3
RRQLLQDPQEPSARS	MRM1	316	Q6IN84
RSNVTVRNTNQRLEP	RNF6	286	Q9Y252
RQSRQASDAPRNQPP	AGMAT	31	Q9BSE5
ENSPDAQPQAGRRTR	SP1	586	P08047
AQRDNPRASRTSSPN	TRIOBP	456	Q9H2D6
QRDNPRASRTSSPNR	TRIOBP	506	Q9H2D6
AQRDNPRASSPNRAA	TRIOBP	531	Q9H2D6
QRDNPRASSPNRATR	TRIOBP	581	Q9H2D6
PNRATRDNPRTSCAQ	TRIOBP	616	Q9H2D6
RDNPRTSCAQRDNPR	TRIOBP	621	Q9H2D6
RDNPRASSPNRTTQQ	TRIOBP	631	Q9H2D6
SSPNRTIQQENPRTS	TRIOBP	661	Q9H2D6
NPRASSPSRTIQQEN	TRIOBP	681	Q9H2D6
PNRTTQQENPRTSCA	TRIOBP	711	Q9H2D6
QQENPRTSCARRDNP	TRIOBP	716	Q9H2D6
RDNPRTSCAQRDNPR	TRIOBP	741	Q9H2D6
RDNPRASSPNRTIQQ	TRIOBP	751	Q9H2D6
LRASSPIRATQQDNP	TRIOBP	801	Q9H2D6
RVIPVTSRNRDNDPN	POLR2C	126	P19387
PSQDQRLQAQRLRNP	SMURF1	201	Q9HCE7
CPRPTLAQRERNQAS	CHRM5	256	P08912
TALRISQSTFNNPRP	NCOA2	861	Q15596
SAQAQPQPSSSSRQR	SUPT6H	1646	Q7KZ85
TPARQRTQRADTQPS	TMEM31	36	Q5JXX7
DRQRRVFQPSPLASQ	UBXN6	271	Q9BZV1
EPRLSRRQVSSPNAQ	ZNF174	256	Q15697
RNQSPQRLASQASRP	SPEN	251	Q96T58
RNPNIQRQPSRQSER	SYNGAP1	726	Q96PV0
QQRAQSPARPRDSSL	SOGA3	36	Q5TF21
RETLPEPNSQGQRNR	UBL3	91	O95164
NVRQFLPPSRQSSRS	SPIRE1	531	Q08AE8
SPVSSPNQLRQDNRQ	SCEL	196	O95171
FTNSLPEARRNSRQP	THSD1	171	Q9NS62
QAQQRRVTPDRSQTS	SORBS1	1216	Q9BX66
SAENRPEQSLPQQRF	SUPT20H	706	Q8NEM7
QPAERRASNDQRPQE	NISCH	1031	Q9Y2I1
RRSRSQTPSCQNLDP	nan	41	A6NN06
NEAVAPEFTNRNPRN	MRPL18	41	Q9H0U6
RAQQQSQRRLSTSPD	UBE2J1	256	Q9Y385
SSQNRPRADPGIQRQ	VIT	236	Q6UXI7
QNQSIRRPSRQLAPN	ROCK2	1371	O75116
PSRNRENETSRQNLS	ST7L	136	Q8TDW4
RQPERNRSGNQRQST	USF3	1991	Q68DE3
LAPQQRAAPQQKRSS	TNFRSF10B	61	O14763
RRSRSQTPSCQNLDP	nan	41	Q5XG85
RPRSVLNTQPEQTNA	NSD3	421	Q9BZ95
GRDPRPQTSRISQEQ	ZBTB2	156	Q8N680
SALDRRAPTRNQPQA	TNFRSF1B	336	P20333
QSPSNLRDNPFRTTQ	PLEKHA5	936	Q9HAU0
AQSQRSVPSGNRPQQ	TNRC6A	1426	Q8NDV7
RNLQSPTQFQTPRSS	ULK1	446	O75385
NRDPRTTAVSSNRNP	nan	381	Q8N7P7
RPNDPGRSRQNSATR	UNC79	1541	Q9P2D8
IRQRTAAQRNLSPTP	LNPK	166	Q9C0E8
PSLRERRPQQELQNQ	MYO3A	1556	Q8NEV4